FDA Approves Protega Pharmaceuticals’ Roxybond for Severe Pain Management

Roxybond is the and only FDA-approved abuse-deterrent immediate-release 10 mg oxycodone formulation designed to reduce abuse of pain medication via intranasal and intravenous routes.